Stemline Therapeutics Company
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
Technology:
Anti-infective Drugs, Stem cell therapy
Industry:
PharmTech, Public
Headquarters:
New York, New York, United States
Founded Date:
2003-08-01
Employees Number:
11-50
Funding Status:
M&A
Investors Number:
1
Total Funding:
107090000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2019-01-15
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership